Research Use Only. Not for human consumption, medical use, diagnosis, or treatment. By purchasing, you agree to laboratory use guidelines.
Retatrutide (RETAKLIK) 40mg
A next-generation, multi-receptor metabolic peptide (triple agonist) developed for the treatment of obesity and type 2 diabetes. It activates the GLP-1, GIP, and glucagon receptors, leading to unprecedented weight loss, improved insulin sensitivity, and broad metabolic enhancements in clinical trials.
Synthetic triple receptor agonist for in vitro and in vivo laboratory research on GLP-1, GIP, and glucagon receptor pathways.
Triple Tested
HPLC & MS verified for consistent potency thresholds.
Priority Post
Discreet Next Day Delivery on all research orders.
Janoshik Analytical Verification
All batches are independently verified. You can cross-reference the batch number with the report library.
View Certificate of Analysis →